Literature DB >> 20852892

The molecular basis of autosomal recessive diseases among the Arabs and Druze in Israel.

Joël Zlotogora1.   

Abstract

The Israeli population mainly includes Jews, Muslim and Christian Arabs, and Druze In the last decade, data on genetic diseases present in the population have been systematically collected and are available online in the Israeli national genetic database ( http://www.goldenhelix.org/server/israeli ). In the non-Jewish population, up to 1 July 2010, the database included molecular data on six diseases relatively frequent in the whole population: thalassemia, familial Mediterranean fever (FMF), cystic fibrosis, deafness, phenylketonuria and congenital adrenal hyperplasia, as well as data on 195 autosomal recessive diseases among Muslim Israeli Arabs, 11 among the Christian Arabs and 31 among Druze. A single mutation was characterized in 149 out of the 238 rare disorders for which the molecular basis was known. In many diseases, mutation had never been observed in any other population and was present in one family only suggesting that it occurred as a de novo event. In other diseases, the mutation was present in more than one community or even in other populations such as Bedouins from the Arab peninsula or Christians from Lebanon. In the 89 other disorders, more than one mutation was characterized either in the same gene or in more than one gene. While it is probable that most of these cases represent random events in some cases such as Bardet Biedl among the Bedouins, the reason may be a selective advantage to the heterozygotes.

Entities:  

Mesh:

Year:  2010        PMID: 20852892     DOI: 10.1007/s00439-010-0890-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.

Authors:  B A Bejjani; D W Stockton; R A Lewis; K F Tomey; D K Dueker; M Jabak; W F Astle; J R Lupski
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Identification of a prevalent founder mutation in an Israeli Muslim Arab village confirms the role of PRCD in the aetiology of retinitis pigmentosa in humans.

Authors:  M J Nevet; S A Shalev; J Zlotogora; N Mazzawi; T Ben-Yosef
Journal:  J Med Genet       Date:  2010-05-27       Impact factor: 6.318

3.  A targeted population carrier screening program for severe and frequent genetic diseases in Israel.

Authors:  Joël Zlotogora; Rivka Carmi; Boaz Lev; Stavit A Shalev
Journal:  Eur J Hum Genet       Date:  2008-12-24       Impact factor: 4.246

4.  Genetic background of congenital chloride diarrhea in high-incidence populations: Finland, Poland, and Saudi Arabia and Kuwait.

Authors:  P Höglund; M Auranen; J Socha; K Popinska; H Nazer; U Rajaram; A Al Sanie; M Al-Ghanim; C Holmberg; A de la Chapelle; J Kere
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

5.  Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.

Authors:  R Bargal; N Avidan; T Olender; E Ben Asher; M Zeigler; A Raas-Rothschild; A Frumkin; O Ben-Yoseph; Y Friedlender; D Lancet; G Bach
Journal:  Hum Mutat       Date:  2001-05       Impact factor: 4.878

6.  Ataxia-telangiectasia: linkage analysis in highly inbred Arab and Druze families and differentiation from an ataxia-microcephaly-cataract syndrome.

Authors:  Y Ziv; M Frydman; E Lange; N Zelnik; G Rotman; C Julier; N G Jaspers; Y Dagan; D Abeliovicz; H Dar; Z Borochowitz; M Lathrop; R A Gatti; Y Shiloh
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

7.  Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome.

Authors:  Ruti Parvari; Eli Hershkovitz; Nili Grossman; Rafael Gorodischer; Bart Loeys; Alexandra Zecic; Geert Mortier; Simon Gregory; Reuven Sharony; Marios Kambouris; Nadia Sakati; Brian F Meyer; Aida I Al Aqeel; Abdul Karim Al Humaidan; Fatma Al Zanhrani; Abdulrahman Al Swaid; Johara Al Othman; George A Diaz; Rory Weiner; K Tahseen S Khan; Ronald Gordon; Bruce D Gelb
Journal:  Nat Genet       Date:  2002-10-21       Impact factor: 38.330

8.  Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel: multiple allelic mutations of the IDUA gene in a small geographic area.

Authors:  G Bach; S M Moskowitz; P T Tieu; A Matynia; E F Neufeld
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Clinical and molecular characterisation of Bardet-Biedl syndrome in consanguineous populations: the power of homozygosity mapping.

Authors:  L Abu Safieh; M A Aldahmesh; H Shamseldin; M Hashem; R Shaheen; H Alkuraya; S A F Al Hazzaa; A Al-Rajhi; F S Alkuraya
Journal:  J Med Genet       Date:  2009-10-26       Impact factor: 6.318

10.  Misleading findings of homozygosity mapping resulting from three novel mutations in NPHS1 encoding nephrin in a highly inbred community.

Authors:  Yaacov Frishberg; Ziva Ben-Neriah; Maija Suvanto; Choni Rinat; Minna Männikkö; Sofia Feinstein; Rachel Becker-Cohen; Hannu Jalanko; Joel Zlotogora; Marjo Kestilä
Journal:  Genet Med       Date:  2007-03       Impact factor: 8.822

View more
  12 in total

1.  Congenital adrenal hyperplasia with beta-thalassemia--a rare association.

Authors:  Vijay N Yewale; Jeetendra Gavhane; Dhanya Dharmapalan; Prashant Weekay; Satish Shahane
Journal:  Indian J Pediatr       Date:  2011-12-17       Impact factor: 1.967

2.  Consecutive mutational events in a TSHR allele of Arab families with resistance to thyroid stimulating hormone.

Authors:  Chutintorn Sriphrapradang; Alina German; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Thyroid       Date:  2012-02-07       Impact factor: 6.568

3.  A review of the diverse genetic disorders in the Lebanese population: highlighting the urgency for community genetic services.

Authors:  Ghunwa Nakouzi; Khalil Kreidieh; Soha Yazbek
Journal:  J Community Genet       Date:  2014-09-27

4.  Whole exome sequencing reveals GUCY2D as a major gene associated with cone and cone-rod dystrophy in Israel.

Authors:  Csilla H Lazar; Mousumi Mutsuddi; Adva Kimchi; Lina Zelinger; Liliana Mizrahi-Meissonnier; Devorah Marks-Ohana; Alexis Boleda; Rinki Ratnapriya; Dror Sharon; Anand Swaroop; Eyal Banin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-16       Impact factor: 4.799

5.  Neurodegenerative disorder related to AIMP1/p43 mutation is not a PMLD.

Authors:  Odile Boespflug-Tanguy; Patrick Aubourg; Imen Dorboz; Mélina Bégou; Geneviève Giraud; Catherine Sarret; Catherine Vaurs-Barrière
Journal:  Am J Hum Genet       Date:  2011-03-11       Impact factor: 11.025

Review 6.  A novel treatment of temporomandibular joint arthritis as a complication in familial Mediterranean fever-literature review and a case report.

Authors:  Boaz Frenkel; Tal Berg; Amir Totry; Adi Rachmiel
Journal:  Oral Maxillofac Surg       Date:  2018-10-19

7.  Runs of homozygosity, copy number variation, and risk for depression and suicidal behavior in an Arab Bedouin kindred.

Authors:  Nadine M Melhem; Sami Hamdan; Lambertus Klei; Shawn Wood; Jamie Zelazny; Amos Frisch; Abraham Weizman; Miri Carmel; Elena Michaelovsky; Ilana Farbstein; Danuta Wasserman; Muhammad El-Heib; Robert Ferrell; Alan Apter; Bernie Devlin; David Brent
Journal:  Psychiatr Genet       Date:  2017-10       Impact factor: 2.458

8.  Genetics and genomic medicine in Israel.

Authors:  Joël Zlotogora
Journal:  Mol Genet Genomic Med       Date:  2014-03       Impact factor: 2.183

9.  Nonsyndromic retinitis pigmentosa is highly prevalent in the Jerusalem region with a high frequency of founder mutations.

Authors:  Dror Sharon; Eyal Banin
Journal:  Mol Vis       Date:  2015-07-17       Impact factor: 2.367

10.  Controversies and considerations regarding the termination of pregnancy for foetal anomalies in Islam.

Authors:  Abdulrahman Al-Matary; Jaffar Ali
Journal:  BMC Med Ethics       Date:  2014-02-05       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.